DURECT Corporation filed its 10-K on Mar 08, 2023 for the period ending Dec 31, 2022. In this report its auditor, Ernst & Young LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.3 USD | +3.17% | +39.78% | +120.34% |
05-21 | Sector Update: Health Care Stocks Edge Higher Tuesday Afternoon | MT |
05-21 | Durect Gets FDA Breakthrough Therapy Designation for Alcohol-Related Hepatitis Treatment | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+120.34% | 40.35M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- DRRX Stock
- News DURECT Corporation
- DURECT Corporation Auditor Raises 'Going Concern' Doubt